Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOL-005 Topical Formulation for Hair Growth in Androgenetic Alopecia
NCT04774874Phase 2Completed
- Sponsor
- Follicum
- Start
- Jun 2020
- Primary completion
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Follicopeptide in androgenetic alopecia (AGA), sponsored by Follicum. Started Jun 2020; status: completed.
02
Drugs
Follicopeptide
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT04774874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04774874.